Delivery Order SPE2DB20D1100-SPE2DB25FE1X2
- Not listed
- The Defense Logistics Agency awarded a $28,473.94 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,867.64 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a $26,943.08 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $30,478.93 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,772.16 and firm fixed pricing. This delivery order is non-set-aside and represents a competitive award for pharmaceutical procurement. The contract is scheduled for ultimate completion by August 20, 2025, with performance executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $23,316.24 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive, firm fixed-price contract is scheduled for completion by September 9, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a $30,796.91 delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of April 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $29,915.39 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes under a firm fixed price contract. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this medical supply delivery order. This delivery order operates as a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1X2Delivery Order
The Defense Logistics Agency awarded a $5,591.47 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dupixent 300 mg/2 ml syringes. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables global pharmaceutical supply to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio with the Defense Logistics Agency and Medical Supply Chain. The company's federal contract awards demonstrate consistent capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As the prime contractor under the broader IDC vehicle, AmerisourceBergen fulfills medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular delivery order supporting the ongoing pharmaceutical supply needs of federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/20/25 |